Book: Cross-Sectional Atlas of the Human Head: With 0.1-mm pixel size color images

Cross-Sectional Atlas of the Human Head: With 0.1-mm pixel size color images

Nov 17, 2017
by Jin Seo Park

List Price:  $129.00

ADD TO SHOPPING CART

This superb color atlas sets a new standard in neuroanatomy by presenting around 300 detailed thin-sectioned images of the human head, including the brain, with 0.1-mm intervals and a pixel size of 0.1 mm × 0.1 mm. A new reference system employed for this purpose is clearly explained, and structures are fully annotated in the horizontal, coronal, and sagittal planes. Recent advances in 7T MRI and 7T TDI have considerably enhanced imaging of the human brain, thereby impacting on both neuroscience research and clinical practice. Moreover, the information gained from initiatives involving photography of thin slices of human cadavers, such as the Visible Human Projects, Visible Korean and Chinese Visible Human, has enriched knowledge of neuroanatomy and thereby facilitated the interpretation of such ultra-high-field resolution images. The exquisite images contained within this atlas will be invaluable in providing both researchers and clinicians with important new insights.

Manual of Peripheral Nerve Surgery: From the Basics to Complex Procedures 1st Edition

Manual of Peripheral Nerve Surgery: From the Basics to Complex Procedures 1st Edition
by Mariano Socolovsky (Editor), Lukas Rasulic (Editor), Rajiv Midha (Editor), Debora Garozzo (Editor)

List Price: $179.99

ADD TO SHOPPING CART

Developed and written by top international experts in the field, this lucid new work is a comprehensive yet concise manual for reviewing the basics of peripheral nerve anatomy, pathophysiology, all typical and classic lesions, and the appropriate diagnostics. The chapters culminate in a description of the complex step-by-step surgical repair of these lesions.

Succinctly written, the manual covers a range of topics normally only seen in larger works: included are the various plexus systems and associated injuries, facial nerve surgery, compression neuropathies and tumors, gunshot wounds, pain management, and much more.

Key Features:

  • Developed and written by members of the World Federation of Neurosurgical Societies (WFNS) Peripheral Nerve Committee
  • Full coverage of all typical nerve lesions from the basics of anatomy and pathophysiology to the most complex surgical solutions
  • Conceived for neurosurgeons, plastic surgeons, orthopaedic surgeons, and hand surgeons, both in training and in professional practice
  • More than 250 images-radiological images, color illustrations, and photographs of dissections-which help in visualizing and comprehending the text better

The Manual of Peripheral Nerve Surgery: From the Basics to Complex Procedures is certain to become a much-used reference resource for residents and practicing surgeons alike.

Neurosurgery Rounds: Questions and Answers

Neurosurgery Rounds: Questions and Answers
Nov 15, 2017
by Mark Shaya and Cristian Gragnaniello

List Price: $38.11

ADD TO SHOPPING CART

Neurosurgery Rounds: Questions and Answers is the first guide dedicated to preparing residents and medical students for the challenging questions – known as pimping in the vernacular – they will frequently encounter on neurosurgery rotation.

Nine succinct chapters fully cover the basic and clinical neurosciences in a convenient Q&A format that is ideal for self-study. Short answers and explanations appear directly below the questions to enable easy reading on the go.

Features

  • Over 1,600 questions and answers quiz readers on a wide range of neurosurgical topics
  • 30 cases – also in an accessible Q&A format – prime readers for clinical situations
  • More than 150 high-quality radiographs and anatomy drawings supplement the text

The perfect size to fit in a lab coat pocket, this concise review will be the constant companion of every medical student on a neurosurgical rotation and every neurosurgery resident or general surgery resident who needs to prepare for rounds or study for board examinations.

The NeuroICU Board Review 1st Edition

The NeuroICU Board Review 1st Edition
by Saef Izzy (Author), David P. Lerner (Author), Kiwon Lee (Author)

List Price: $125.00

ADD TO SHOPPING CART

The NeuroICU Board Review is a comprehensive board exam and curriculum review for the emerging specialty of neurocritical care. It delivers a through overview of neurological disease states (pathology, pathophysiology, and therapy), neurosurgery, and critical care medicine (including medical, surgical, cardiac, and cardiothoracic critical care), along with important  topics such as neuromonitoring, neurosurgical emergencies, neuropharmacology, and neurosurgical post-operative care. This powerful review also includes clinical scenarios and more than 800 questions and answers with detailed answer explanations, with accompanying images, illustrations, tables, and detailed references.

• Developed for residents and practicing physicians preparing to take certifying board exams in  Neurocritical Care, Surgical Critical Care, and Neurological Surgery
• More than 800 Q&A with detailed answer explanations
• Clinical scenarios show readers how to apply principles to real-world cases

Update: GLARIUS trial

GLARIUS trial

The GLARIUS trial which investigated the efficacy of bevacizumab (BEV)/irinotecan (IRI) as compared to standard temozolomide (TMZ) in the first-line therapy of MGMT promoter methylation glioblastoma showed that progression free survival was significantly prolonged by BEV/IRI while overall survival was similar in both arms 1).


A report focusses on quality of life (QoL) and Karnofsky performance score (KPS) during the whole course of the disease.

Patients (n=170) received standard radiotherapy and were randomized (2:1) for BEV/IRI or standard TMZ. At least every three months KPS was determined and QoL was measured using the EORTC QLQ-C30 and EORTC QLQ-BN20 questionnaires. A generalized estimating equation model (GEE) evaluated differences in the course of QoL and KPS over time. Also, the time to first deterioration and the time to postprogression deterioration was analyzed separately.

In all dimensions of QoL and KPS, GEE analyses and time to first deterioration analyses did not detect significant differences between the treatment arms. At progression, 82% of patients receiving second-line therapy in the standard arm received BEV second-line therapy. For the dimensions motor dysfunction and headaches, time to postprogression deterioration was prolonged in the standard arm receiving crossover second-line BEV in the vast majority of patients at the time of evaluation.

GLARIUS did not find indications for a BEV-induced detrimental effect on QoL in first-line therapy of MGMT-nonmethylated GBM patients. Moreover, GLARIUS provided some indirect corroborative data supporting the notion that BEV may have beneficial effects upon QoL in relapsed GBM 2).

1)

Herrlinger U, Schäfer N, Steinbach JP, Weyerbrock A, Hau P, Goldbrunner R, Friedrich F, Rohde V, Ringel F, Schlegel U, Sabel M, Ronellenfitsch MW, Uhl M, Maciaczyk J, Grau S, Schnell O, Hänel M, Krex D, Vajkoczy P, Gerlach R, Kortmann RD, Mehdorn M, Tüttenberg J, Mayer-Steinacker R, Fietkau R, Brehmer S, Mack F, Stuplich M, Kebir S, Kohnen R, Dunkl E, Leutgeb B, Proescholdt M, Pietsch T, Urbach H, Belka C, Stummer W, Glas M. Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial. J Clin Oncol. 2016 May 10;34(14):1611-9. doi: 10.1200/JCO.2015.63.4691. Epub 2016 Mar 14. PubMed PMID: 26976423.

2)

Schäfer N, Proescholdt M, Steinbach JP, Weyerbrock A, Hau P, Grauer O, Goldbrunner R, Friedrich F, Rohde V, Ringel F, Schlegel U, Sabel M, Ronellenfitsch MW, Uhl M, Grau S, Hänel M, Schnell O, Krex D, Vajkoczy P, Tabatabai G, Mack F, Schaub C, Tzaridis T, Nießen M, Kebir S, Leutgeb B, Urbach H, Belka C, Stummer W, Glas M, Herrlinger U. Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma. Neuro Oncol. 2017 Nov 7. doi: 10.1093/neuonc/nox204. [Epub ahead of print] PubMed PMID: 29121274.